BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  DNAe’s LiDia BSI Test Demonstrates Rapid and Sensitive Identification of Bloodstream Infections Direct From Whole Blood Samples

  The authors of the poster at DNAe confirmed end-to-end functionality of the LiDia BSI workflow, correctly identifying pathogens and resistance genes at 1 colony-forming unit per ml.

  November 20, 2017

   · 

  4 min read
• Business

  Eleven Biotherapeutics Reports Third Quarter 2017 Financial Results

  Cash and cash equivalents were $11.3 million as of September 30, 2017, compared to $25.3 million as of December 31, 2016.

  November 20, 2017

   · 

  11 min read
• Lone Star Bio

  ASPiRA Labs Announces Release of Final CMS Reimbursement Rate for OVA1

  ASPiRA LABS and the exclusive distributor of OVA1, and Overa, today announced that the CMS has released the Final 2018 Clinical Lab Fee Schedule, effective January 1, 2018.

  November 20, 2017

   · 

  5 min read
• Genetown

  Check-Cap Announces $2.5M Registered Direct Offering

  Check-Cap today announced that it has entered into definitive agreements with institutional investors for the purchase of 2,272,640 ordinary shares, at a purchase price of $1.10 per share.

  November 20, 2017

   · 

  4 min read
• Business

  SQI Signs Agreement With a World-Leading Pharmaceutical Company

  SQI is in a unique position with its multiplexing technology to develop an automated, multiplexed test to measure these drug-biomarker interactions.

  November 20, 2017

   · 

  4 min read
• Drug Development

  ATCC Develops Novel in Vitro Model to Investigate Drug Candidates for Cancer Metastasis

  This model is part of a larger effort by ATCC researchers to develop a portfolio of clinically relevant models and biomaterials for therapeutic discovery and development.

  November 20, 2017

   · 

  2 min read
• Lone Star Bio

  Houston-Area Resident Carrie Rand Reestablishes Her Running Career After Total Knee Replacement Surgery

  Unique knee implant allowed her to lose nearly 70 pounds and get back into running shape.

  November 20, 2017

   · 

  3 min read
• Policy

  Paradigm Spine, LLC Announces - Highmark is 1st Private Payor to Issue Exclusive Positive Coverage Policy for coflex Interlaminar Stabilization Treatment of Lumbar Spinal Stenosis

  Paradigm Spine, LLC, a leader in providing solutions for the treatment of lumbar spinal stenosis announces issuance of a Highmark.

  November 20, 2017

   · 

  2 min read
• 

  Drug Development

  DBV Technologies Surges as Peanut Allergy Drug Passes Phase III Test

  Blinded period evaluated the safety of Viaskin Peanut versus placebo in children four to 11 years of age, Including patients with a history of severe anaphylaxis.

  November 20, 2017

   · 

  9 min read
• Lone Star Bio

  Caris Life Sciences to Present at the 29th Annual Piper Jaffray Healthcare Conference

  Company leadership will discuss its two proprietary, precision medicine technology platforms, ADAPT Biotargeting System and Caris Molecular Intelligence, in addition to taking questions from the audience.

  November 20, 2017

   · 

  1 min read